TP53 and neoplasm: P53 mutations are frequently observed in aggressive lymphomas, such as diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and Burkitt lymphoma, where they correlate with high tumor proliferation rates and immune escape 27.